natural killer T-cell inhibiting antibodies (Cephalon Australia)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namenatural killer T-cell inhibiting antibodies (Cephalon Australia)
Drug Alias Namenatural killer T-cell inhibiting antibodies (Innate Immune)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionImmunomodulatorsNatural killer T-lymphocyte inhibitors
TargetsUpdating
Therapy Area/IndicationsLupus Erythematosus, SystemicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInnate Immune Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCephalon Australia Pty LtdInnate Immune Inc
Active IndicationsN/A
Inactive IndicationsLupus Erythematosus, SystemicAsthma

Other Information

ATC CodeN/A
Related LinksN/A